Inventor · disambiguated record
Joseph Francis Krzyzaniak
Also filed as: KRZYZANIAK JOSEPH F · KRZYZANIAK JOSEPH FRANCIS
16 granted patents·7 pending applications·153 citations·filing 2002–2017
93Inventor score
Top patents by PatentIndex Score
23 records- 0196US6605729B1Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2002·Granted Aug 12, 2003·104 cites·15 claims
- 0289US7875731B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acidPFIZER·Filed 2005·Granted Jan 25, 2011·9 cites·4 claims
- 0386US8822703B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acidPFIZER·Filed 2013·Granted Sep 2, 2014·5 cites·6 claims
- 0485US9309195B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatanoic acidPFIZER·Filed 2015·Granted Apr 12, 2016·3 cites·4 claims
- 0585US8552207B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acidKRZYZANIAK JOSEPH F·Filed 2012·Granted Oct 8, 2013·6 cites·3 claims
- 0685US8236966B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acidKRZYZANIAK JOSEPH F·Filed 2010·Granted Aug 7, 2012·6 cites·8 claims
- 0782US8895758B2Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-Dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2013·Granted Nov 25, 2014·4 cites·1 claims
- 0880US9199932B2Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2014·Granted Dec 1, 2015·3 cites·3 claims
- 0980US9073852B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acidPFIZER·Filed 2014·Granted Jul 7, 2015·2 cites·4 claims
- 1080US7144915B2Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2003·Granted Dec 5, 2006·9 cites·46 claims
- 1177US9481647B2Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-Phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER-LAMBERT COMPANY LLC·Filed 2015·Granted Nov 1, 2016·2 cites·3 claims
- 1268US7534810B2Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acidPFIZER·Filed 2008·Granted May 19, 2009·0 cites·7 claims
- 1367US9908850B2Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acidPFIZER·Filed 2017·Granted Mar 6, 2018·0 cites·2 claims
- 1466US2008188652A1Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acidPFIZER·Filed 2008·Application pending·0 cites
- 1565US2008287521A1Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)PFIZER·Filed 2008·Application pending·0 cites
- 1663US9637449B2Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic-acidPFIZER·Filed 2016·Granted May 2, 2017·0 cites·4 claims
- 1763US2008214651A1Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)PFIZER·Filed 2007·Application pending·0 cites
- 1857US2018009748A1Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)WARNER-LAMBERT COMPANY LLC·Filed 2017·Application pending·0 cites
- 1956US8026376B2Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1)PFIZER·Filed 2005·Granted Sep 27, 2011·0 cites·6 claims
- 2049US2011046385A1Polymorphs Of Prostaglandin Agonists And Methods For Making The SamePFIZER PROD INC·Filed 2008·Application pending·0 cites
- 2147US6683106B2N-(indole-2-carbonyl)-b-alaninamide crystal formsPFIZER·Filed 2003·Granted Jan 27, 2004·0 cites·12 claims
- 2246US2007276027A1Crystalline Forms of [R-(R* ,R*)]-2-(4-Fluorophenyl)-Beta, -Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic AcidWARNER LAMBERT CO·Filed 2004·Application pending·0 cites
- 2345US2004152758A1N-(indole-2-carbonyl)-b-alaninamide crystal formsPFIZER·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Francis Krzyzaniak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →